SHL
The Swedish Hockey League takes concussion treatment seriously
Concussions are a serious but all too often underestimated problem in ice hockey. However, in recent years the Swedish Hockey League has...
2021 was a breakthrough year for PolarCool
In 2021, PolarCool made significant progress in its ambition...
Swiss breakthrough for PolarCool
Recently, increasing international attention has...
PolarCool signs agreement with Swedish top hockey leagues
PolarCools
PolarCool aims for more top leagues
Earlier this summer, BioStock reported that PolarCool's PolarCap...
The Swedish national handball team will use the PolarCap System
PolarCool announced on Wednesday that the Swedish handball team...
PolarCool takes a new approach to treating brain injuries
Concussions are common in contact sports, and athletes'...
Interview: BrainCool about the expanded collaboration with the Swedish Hockey League
Medical cooling company BrainCool announced on Tuesday that...
Notes
iZafe takes the next step in the Nordics – begins Finnish partnership for Dosell
Senzime's partner receives FDA approval for TetraGraph module
Ellen sells the business for SEK 13,3 million
Oncopeptides increases sales in the second quarter
Alvotech acquires Ivers-Lee Group in Switzerland
NEWSLETTER
NEWS
Merck gears up in lung diseases with giant acquisition
AstraZeneca strengthens gene therapy portfolio with deals worth up to $825 million
AlzeCure Pharma: “We have good momentum”
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The EU's new life science strategy – a step in the right direction or just fluff?
Early signs of spring in an otherwise frosty biotech landscape
